Prot #AV-951-18-121: A Phase 1b/2, Open-Label, Study of Tivozanib in Combination with Durvalumab in Subjects with Untreated Advanced Hepatocellular Carcinoma

Project: Research project

Project Details

StatusFinished
Effective start/end date5/5/20 → 5/5/23

Funding

  • Pharm-Olam International Ltd. (Prot #AV-951-18-121)
  • AVEO Pharmaceuticals, Inc. (Prot #AV-951-18-121)